LORD, ABBETT & CO. LLC - CADENCE PHARMACEUTICALS INC ownership

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 90 filers reported holding CADENCE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 3.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$8,208,000
+188.4%
906,907
+101.0%
0.02%
+157.1%
Q3 2013$2,846,000
-50.6%
451,106
-46.5%
0.01%
-46.2%
Q2 2013$5,756,000843,9570.01%
Other shareholders
CADENCE PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
OMNI PARTNERS LLP 250,000$3,500,0005.20%
BlackRock Institutional Trust Company, N.A. 6,178$86,0000.00%
CITIGROUP INC 13,052$183,0000.00%
View complete list of CADENCE PHARMACEUTICALS INC shareholders